Neena M Patil sold $11M of JAZZ
EVP & Chief Legal Officer at Jazz Pharmaceuticals plc. 55,600 shares at an average of $191.56, traded Feb 26, 2026, filed Mar 2, 2026.
Score components
- +15RoleOfficer
- +25Trade size$10.7M at market
- +20Share of holdings soldSold 76% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001783908-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | MOption exercise Ordinary Shares | +20,125 | $113.10 | $2.3M | 73,464 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -16,602 | $192.53 | $3.2M | 56,862 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Ordinary Shares | +875 | $113.10 | $99k | 57,737 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -875 | $192.07 | $168k | 56,862 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Ordinary Shares | +27,084 | $137.12 | $3.7M | 83,946 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -15,555 | $190.28 | $3.0M | 68,391 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Ordinary Shares | +2,916 | $137.12 | $400k | 71,307 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -2,916 | $189.81 | $553k | 68,391 | Mar 2, 2026 |
| Feb 26, 2026 | AGrant or award Ordinary Shares | +10,079 | $0.00 | $0 | 78,470 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -11,529 | $191.65 | $2.2M | 66,941 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -3,523 | $193.58 | $682k | 63,418 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -1,061 | $190.00 | $202k | 62,357 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -549 | $190.80 | $105k | 61,808 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -1,784 | $191.88 | $342k | 60,024 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -1,009 | $192.79 | $195k | 59,015 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Ordinary Shares | -197 | $193.60 | $38k | 58,818 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Incentive Stock Option (right to buy)derivative | -875 | $0.00 | $0 | 0 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Incentive Stock Option (right to buy)derivative | -2,916 | $0.00 | $0 | 0 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -20,125 | $0.00 | $0 | 0 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -27,084 | $0.00 | $0 | 0 | Mar 2, 2026 |
Related signals
Other insiders at Jazz Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Jazz Pharmaceuticals plc | Renee D Gala President & CEO | $473k 2,000 shares | -1% | |
| 28Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.4M 6,000 shares | -2% | |
| 24Weak | Jazz Pharmaceuticals plc | Neena M Patil EVP & Chief Legal Officer | $289k 1,200 shares | -2% | |
| 38Weak | Jazz Pharmaceuticals plc | Renee D Gala President & CEO | $486k 2,000 shares | -1% | |
| 45Moderate | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.5M 6,000 shares | -2% | |
| 20Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.4M 6,000 shares | -2% | |
| 20Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.2M 6,000 shares | -2% | |
| 20Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.1M 6,000 shares | -2% | |
| 48Moderate | Jazz Pharmaceuticals plc | Patricia Carr SVP, Chief Accounting Officer | $235k 1,287 shares | -17% | |
| 35Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.1M 6,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.